Total Funding
14
Total FundingSeed raised
Growth Score
pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Liquid Biotech is a technology for cancer diagnostics and gene discover
- Jay Dorsey: Co-Founder
- Stephen Hahn: Co-FounderPast Role: Harbinger Health, CEO at Harbinger Health, CEO-Partner at Flagship Pioneering
About the Company
Liquid Biotech is a developer of non-invasive blood tests for cancer. With the company's method, serial biopsies can be performed with little risk, live cancer cells can be isolated, and the genetic information from those cells can be used by the oncologist to guide therapy (personalized medicine). Cancer diagnosis and prognosis, as well as
the emergence of therapeutic resistance mechanisms, are just a few of the many topics covered by Liquid Biotech's technology.
